Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thiotepa-busulfan-fludarabine as a conditioning regimen for patients with myelofibrosis undergoing allogeneic hematopoietic transplantation: a single center experience.
Memoli M, Paviglianiti A, Malard F, Battipaglia G, Brissot E, Médiavilla C, Bianchessi A, Banet A, Van de Wyngaert Z, Ledraa T, Belhocine R, Sestili S, Lapusan S, Hirsch P, Favale F, Boussaroque A, Bonnin A, Vekhoff A, Legrand O, Mohty M, Duléry R. Memoli M, et al. Among authors: favale f. Leuk Lymphoma. 2021 Feb;62(2):419-427. doi: 10.1080/10428194.2020.1827246. Epub 2020 Oct 5. Leuk Lymphoma. 2021. PMID: 33012207
Use of the 46/1 haplotype to model JAK2(V617F) clonal architecture in PV patients: clonal evolution and impact of IFNα treatment.
Hasan S, Cassinat B, Droin N, Le Couedic JP, Favale F, Monte-Mor B, Lacout C, Fontenay M, Dosquet C, Chomienne C, Solary E, Villeval JL, Casadevall N, Kiladjian JJ, Vainchenker W, Plo I. Hasan S, et al. Among authors: favale f. Leukemia. 2014 Feb;28(2):460-3. doi: 10.1038/leu.2013.303. Epub 2013 Oct 22. Leukemia. 2014. PMID: 24150219 No abstract available.
Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia.
Hirsch P, Tang R, Abermil N, Flandrin P, Moatti H, Favale F, Suner L, Lorre F, Marzac C, Fava F, Mamez AC, Lapusan S, Isnard F, Mohty M, Legrand O, Douay L, Bilhou-Nabera C, Delhommeau F. Hirsch P, et al. Among authors: favale f. Haematologica. 2017 Jul;102(7):1227-1237. doi: 10.3324/haematol.2016.159681. Epub 2017 Mar 16. Haematologica. 2017. PMID: 28302711 Free PMC article.
Prognostic impact of early minimal residual disease combined with complete molecular evaluation in acute myeloid leukemia with mutated NPM1: a single center study.
Memoli M, Genthon A, Favale F, Lapusan S, Johnson N, Adaeva R, Deswarte C, Battipaglia G, Malard F, Duléry R, Brissot E, Banet A, Van de Wyngaert Z, Mohty M, Delhommeau F, Legrand O, Hirsch P. Memoli M, et al. Among authors: favale f. Leuk Lymphoma. 2022 Sep;63(9):2171-2179. doi: 10.1080/10428194.2022.2064987. Epub 2022 Apr 22. Leuk Lymphoma. 2022. PMID: 35459427
Isocitrate dehydrogenase inhibitors as a bridge to allogeneic stem cell transplant in relapsed or refractory acute myeloid leukaemia.
Genthon A, Dragoi D, Memoli M, Hirsch P, Favale F, Suner L, Chaquin M, Boncoeur P, Marjanovic Z, Bonnin A, Sestili S, Dulery R, Malard F, Brissot E, Banet A, van de Wyngaert Z, Vekhoff A, Delhommeau F, Mohty M, Legrand O. Genthon A, et al. Among authors: favale f. Br J Haematol. 2022 Aug;198(4):780-784. doi: 10.1111/bjh.18290. Epub 2022 May 26. Br J Haematol. 2022. PMID: 35615877 No abstract available.
Clinical and biological impact of ATP-binding cassette transporter activity in adult acute myeloid leukemia.
Sourdeau E, Suner L, Memoli M, Genthon A, Feger F, Soret L, Abermil N, Heuberger L, Bilhou-Nabera C, Guermouche H, Favale F, Lapusan S, Chaquin M, Hirschauer C, Mohty M, Legrand O, Delhommeau F, Hirsch P. Sourdeau E, et al. Among authors: favale f. Haematologica. 2023 Jan 1;108(1):61-68. doi: 10.3324/haematol.2022.280676. Haematologica. 2023. PMID: 35924580 Free PMC article.
Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia.
Tamburini J, Mouche S, Larrue C, Duployez N, Bidet A, Salotti A, Hirsch P, Rigolot L, Carras S, Templé M, Favale F, Flandrin-Gresta P, Le Bris Y, Alary AS, Mauvieux L, Tondeur S, Delabesse E, Delhommeau F, Sujobert P, Kosmider O. Tamburini J, et al. Among authors: favale f. Blood Adv. 2023 Dec 26;7(24):7576-7580. doi: 10.1182/bloodadvances.2023011916. Blood Adv. 2023. PMID: 37987760 Free PMC article. No abstract available.
Myelofibrosis, JAK2 inhibitors and erythropoiesis.
Vainchenker W, Favale F. Vainchenker W, et al. Among authors: favale f. Leukemia. 2013 Jun;27(6):1219-23. doi: 10.1038/leu.2013.72. Leukemia. 2013. PMID: 23739260 No abstract available.
Author Correction: JAK2V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysm.
Al-Rifai R, Vandestienne M, Lavillegrand JR, Mirault T, Cornebise J, Poisson J, Laurans L, Esposito B, James C, Mansier O, Hirsch P, Favale F, Braik R, Knosp C, Vilar J, Rizzo G, Zernecke A, Saliba AE, Tedgui A, Lacroix M, Arrive L, Mallat Z, Taleb S, Diedisheim M, Cochain C, Rautou PE, Ait-Oufella H. Al-Rifai R, et al. Among authors: favale f. Nat Commun. 2022 Dec 23;13(1):7921. doi: 10.1038/s41467-022-35645-z. Nat Commun. 2022. PMID: 36564399 Free PMC article. No abstract available.
19 results